You Position: Home > Paper

A clinical study of minimal invasive operation coalesced with urokinase to eliminate hematomas of the hypertensive cerebral hemorrhage

( views:253, downloads:16 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
Issue:
4
DOI:
10.3760/cma.j.issn.1008-6706.2004.04.005
Key Word:
高血压脑出血;微创手术;尿激酶

Abstract: 目的探讨微创小骨窗血肿清除加用尿激酶溶解血肿治疗高血压脑出血的效果.方法将32例入院的高血压脑出血病例在头颅CT片指导下行颞部直切口,小骨窗2.0~3.0 cm,直视下吸除大部血肿,活动性出血予以电凝止血.血肿腔放置硅胶管,手术后3d引流管注入1万U尿激酶,再引流陈旧溶解的血肿液,并与大骨瓣开颅血肿清除术的效果相比较.结果 32例中,18例完全恢复,半自理8例,优良率81.3%,偏瘫4例,无植物生存,死亡2例,病死率6%.与前期大骨瓣开颅血肿清除术相比较有良好的效果.结论小骨窗微创血肿清除加尿激酶血肿腔溶解血肿的结合,最佳化地发挥了各自的优势,同时避免了其缺点.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn